Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness

Major histocompatibility complex (MHC) class I molecules are cell- surface proteins that present peptides to CD8+ T cells. These peptides are mostly derived from endogenously synthesized protein. Recombinant, soluble MHC class I molecules were produced, purified, and loaded homogeneously with synthetic peptide. These MHC-peptide complexes were used to activate a T cell hybridoma. While monomers of MHC-peptide bound to the T cell, they showed no stimulatory activity. Dimers fully triggered the T cell hybridoma to secrete interleukin 2. This response was followed by a state in which the T cell was refractory to restimulation as a result of defective signal transduction through the T cell receptor.

[1]  R. Fisher,et al.  T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. , 1995, Science.

[2]  L. Samelson,et al.  Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists , 1995, Science.

[3]  Paul M. Allen,et al.  Partial T cell signaling: Altered phospho-ζ and lack of zap70 recruitment in APL-induced T cell anergy , 1994, Cell.

[4]  A. Trautmann,et al.  Antigen recognition by helper T cells elicits a sequence of distinct changes of their shape and intracellular calcium , 1994, Current Biology.

[5]  P. Kourilsky,et al.  Major contribution of the Vb chain to the antigen specificity of a TCR , 1994 .

[6]  R. J. Cohen,et al.  Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. , 1994, Immunity.

[7]  P. Kourilsky,et al.  The V beta complementarity determining region 1 of a major histocompatibility complex (MHC) class I-restricted T cell receptor is involved in the recognition of peptide/MHC I and superantigen/MHC II complex , 1994, The Journal of experimental medicine.

[8]  M. Kaufman,et al.  T cell long‐term hyporesponsiveness follows antigen receptor engagement and results from defective signal transduction , 1994, European journal of immunology.

[9]  K. Karjalainen.  High sensitivity, low affinity--paradox of T-cell receptor recognition. , 1994, Current opinion in immunology.

[10]  Dan R. Littman,et al.  Signal transduction by lymphocyte antigen receptors , 1994, Cell.

[11]  T. Schumacher,et al.  A soluble, single‐chain Kd molecule produced by yeast selects a peptide repertoire indistinguishable from that of cell‐surface‐associated Kd , 1993, European journal of immunology.

[12]  B. Seed,et al.  T cell activation by clustered tyrosine kinases , 1993, Cell.

[13]  J. Allison,et al.  CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help , 1993, The Journal of experimental medicine.

[14]  P. Benaroch,et al.  Tetramer data reinterpreted , 1993, Nature.

[15]  R. Hausmann,et al.  Interaction of papain‐digested HLA class I molecules with human alloreactive cytotoxic T lymphocytes (CTL) , 1993, Clinical and experimental immunology.

[16]  D. Margulies,et al.  A recombinant, soluble, single-chain class I major histocompatibility complex molecule with biological activity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[17]  H. Dintzis,et al.  Inhibition or activation of human T cell receptor transfectants is controlled by defined, soluble antigen arrays , 1992, The Journal of experimental medicine.

[18]  J. Casanova,et al.  H-2-restricted cytolytic T lymphocytes specific for HLA display T cell receptors of limited diversity , 1992, The Journal of experimental medicine.

[19]  R. Klausner,et al.  High-efficiency expression and solubilization of functional T cell antigen receptor heterodimers. , 1992, Science.

[20]  M. Davis,et al.  Low affinity interaction of peptide-MHC complexes with T cell receptors. , 1991, Science.

[21]  M. Jenkins,et al.  CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. , 1991, Journal of immunology.

[22]  F. Salemme,et al.  The identification of tyrosine as a common key residue in unrelated H-2Kd restricted antigenic peptides. , 1991, International immunology.

[23]  I Nicoletti,et al.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.

[24]  M. Kaufman,et al.  Induction of long-term but reversible unresponsiveness after activation of murine T cell hybridomas. , 1991, International immunology.

[25]  P. Kourilsky,et al.  A single‐chain murine class I major transplantation antigen , 1991, European journal of immunology.

[26]  K. Horgan,et al.  The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. , 1990, Journal of immunology.

[27]  U. Koszinowski,et al.  Transgenic mice expressing a soluble foreign H-2 class I antigen are tolerant to allogeneic fragments presented by self class I but not to the whole membrane-bound alloantigen. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Ashwell,et al.  Activation-driven T cell death. I. Requirements for de novo transcription and translation and association with genome fragmentation. , 1989, Journal of immunology.

[29]  B. Malissen,et al.  Derivation of a T cell hybridoma variant deprived of functional T cell receptor α and β chain transcripts reveals a nonfunctional α‐mRNA of BW5147 origin , 1989, European journal of immunology.

[30]  I. Mellman,et al.  Fc receptor isoforms exhibit distinct abilities for coated pit localization as a result of cytoplasmic domain heterogeneity , 1989, Cell.

[31]  C. Janeway,et al.  Physical association of CD4 and the T-cell receptor can be induced by anti-T-cell receptor antibodies. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[32]  D. Margulies,et al.  T cell activation by purified, soluble, class I MHC molecules. Requirement for polyvalency. , 1988, Journal of immunology.

[33]  T. Strachan,et al.  Mapping of HLA epitopes recognized by H-2-restricted cytotoxic T lymphocytes specific for HLA using recombinant genes and synthetic peptides. , 1988, Journal of immunology.

[34]  P. Kourilsky,et al.  Fine mapping of epitopes by intradomain Kd/Dd recombinants , 1987, The Journal of experimental medicine.

[35]  R. E. Cunningham,et al.  Cell growth cycle block of T cell hybridomas upon activation with antigen , 1987, The Journal of experimental medicine.

[36]  B. Jordan,et al.  H2-restricted recognition of cloned HLA class I gene products expressed in mouse cells. , 1986, Journal of immunology.

[37]  J. Vernachio,et al.  Qa gene expression: biosynthesis and secretion of Qa-2 molecules in activated T cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. McMichael,et al.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides , 1986, Cell.

[39]  R. Siliciano,et al.  Antigen valence determines the binding of nominal antigen to cytolytic T cell clones , 1985, The Journal of experimental medicine.

[40]  G. Khoury,et al.  Secretion of a transplantation-related antigen , 1983, Cell.

[41]  J. Lamb,et al.  Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin , 1983, The Journal of experimental medicine.

[42]  P. Kourilsky,et al.  A new dominant hybrid selective marker for higher eukaryotic cells. , 1981, Journal of molecular biology.

[43]  B. Vogelstein,et al.  Molecular determinants of immunogenicity: the immunon model of immune response. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[44]  M. Folan.  Immunological Tolerance , 1956, Journal of the Irish Medical Association.

[45]  K. Kuwano,et al.  Immobilized anti-TCR mAb induces split functions in a CD8+ CTL clone. , 1994, Cellular immunology.

[46]  C. Janeway,et al.  The immune system evolved to discriminate infectious nonself from noninfectious self. , 1992, Immunology today.

[47]  P. Kourilsky,et al.  Purification and ligand binding of a soluble class I MHC molecule consisting of the first three domains of H-2Kd fused to b2-microglobulin expressed in the baculovirus/insect cell system , 1992 .

[48]  C. Janeway,et al.  Monoclonal antibodies against T cell receptor/CD3 complex induce cell death of Th1 clones in the absence of accessory cells. , 1991, Advances in experimental medicine and biology.

[49]  D. Margulies,et al.  Mice transgenic for a gene that encodes a soluble, polymorphic class I MHC antigen. , 1991, Biotechnology.

[50]  C. Janeway,et al.  Cross-linking and conformational change in T-cell receptors: role in activation and in repertoire selection. , 1989, Cold Spring Harbor symposia on quantitative biology.

[51]  P. Robinson,et al.  Two different biosynthetic pathways for the secretion of Qa region-associated class I antigens by mouse lymphocytes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Edward,et al.  Specific cellular stimulation in the primary immune response: A quantized model , 2022 .